[Relationship between overexpression of HER-2/neu protein and prognosis in epithelial ovarian cancer]

Nihon Rinsho. 2004 Oct:62 Suppl 10:582-6.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antibody-Dependent Cell Cytotoxicity
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Carcinoma / diagnosis
  • Carcinoma / drug therapy
  • Carcinoma / genetics*
  • Drug Resistance, Neoplasm / genetics
  • Female
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / genetics*
  • Prognosis
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / genetics*
  • Receptor, ErbB-2 / immunology
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Receptor, ErbB-2
  • Trastuzumab